Building a High-Quality IVF Laboratory: The Essential Elements of a Modern Quality Management System
Rada Medical

Building a High-Quality IVF Laboratory: The Essential Elements of a Modern Quality Management System

An IVF laboratory is one of the most controlled and technically demanding environments in reproductive medicine. Every stage—from gamete handling and fertilization to embryo culture, transfer, and cryopreservation—can influence the quality and safety of assisted reproduction. Because these processes involve highly sensitive biological material, quality cannot depend solely on the expertise of individual embryologists. It must be built into the laboratory's entire operating system.

A modern Quality Management System (QMS) provides that structure. It establishes how personnel, equipment, materials, facilities, procedures, documentation, risks, incidents, and performance are controlled and continuously improved. The World Health Organization describes laboratory quality management as a comprehensive approach covering the organizational structure, processes, procedures, resources, and activities that influence laboratory performance.

For IVF laboratories, the importance of this approach is even greater because errors may affect reproductive cells and embryos that cannot simply be replaced or retested. The updated 2026 European Society of Human Reproduction and Embryology (ESHRE) recommendations specifically emphasize quality management, laboratory safety, patient identification, traceability, equipment and materials, documentation, embryo culture and transfer, cryopreservation, and emergency procedures.

 

  1. Quality Starts With Leadership and Clear Responsibility

A high-quality IVF laboratory begins with defined accountability. The laboratory director should have clear responsibility for scientific and clinical laboratory performance, while a designated quality manager or equivalent function should coordinate the QMS.

Quality management should not be treated as an administrative task belonging exclusively to the quality manager. Embryologists, andrologists, clinicians, technicians, maintenance personnel, and management all influence laboratory quality.

The 2026 ESHRE recommendations identify responsibilities including implementation of the QMS, development and review of standard operating procedures (SOPs), equipment and facility management, risk management, staff training, quality indicators, audits, and adverse-event reporting.

In practical terms, an IVF laboratory should have documented responsibilities for:

  • Laboratory direction and clinical oversight
  • Quality management
  • Equipment qualification and maintenance
  • Staff training and competency assessment
  • Biological-material traceability
  • Incident and non-conformity management
  • Emergency response
  • Document control
  • Internal audits and management review

Clear responsibility reduces the risk that important quality activities become "everyone's job" and therefore nobody's responsibility.

 

  1. Build the QMS Around the Entire Laboratory Workflow

A QMS should not be a collection of documents stored in a quality folder. It should describe how the laboratory actually operates.

The WHO Laboratory Quality Management System framework emphasizes that quality must address the complete laboratory process rather than isolated testing activities.

In IVF, the workflow can be viewed from patient identification and collection through laboratory processing, culture, storage, transfer, and follow-up. Every transition represents a potential point of failure.

For each critical process, the laboratory should define:

  1. What is being performed?
  2. Who is authorized to perform it?
  3. Which equipment and materials are required?
  4. Which environmental conditions must be maintained?
  5. What records must be generated?
  6. What constitutes an acceptable result?
  7. What happens when something goes wrong?

This process-based approach transforms quality from a concept into a reproducible operating system.

 

  1. Standard Operating Procedures Must Reflect Actual Practice

SOPs are fundamental to consistency. They should provide sufficiently detailed instructions for critical procedures while remaining practical for the staff who use them.

Important IVF laboratory procedures should have controlled SOPs covering areas such as sperm preparation, oocyte handling, insemination and ICSI, embryo culture, embryo assessment, embryo transfer support, cryopreservation, warming, witnessing and identification, equipment operation, cleaning, environmental monitoring, and emergency response.

An SOP should specify its version, approval status, effective date, responsible owner, review date, and change history.

The WHO quality-management framework emphasizes the importance of controlled documentation and maintaining current procedures.

An outdated SOP can be worse than having no SOP because it creates a false sense of control.

 

  1. Personnel Competence Is a Core Quality Control

Even the most advanced IVF laboratory cannot achieve consistent performance without competent personnel.

Training should extend beyond initial orientation. Staff should receive structured training when joining the laboratory and continuing education throughout their careers. Competency should be assessed objectively for critical procedures rather than assumed from experience alone.

A practical competency program can include:

  • Initial competency assessment
  • Direct observation
  • Procedure-specific authorization
  • Periodic reassessment
  • Review of laboratory performance indicators
  • Training following equipment or process changes
  • Documentation of continuing professional development

ESHRE's current recommendations specifically identify appropriate staffing, orientation, training, continuing education, and professional development as responsibilities of laboratory leadership.

Competence should also be linked to authorization: staff should perform only procedures for which their training and demonstrated competence have been documented.

 

  1. Equipment Must Be Controlled Throughout Its Life Cycle

IVF laboratories depend heavily on equipment such as incubators, microscopes, centrifuges, cryogenic storage systems, workstations, witnessing systems, and environmental monitoring devices.

Equipment management should begin before installation and continue until decommissioning.

A practical equipment program should include:

  • Defined specifications before purchase
  • Supplier qualification where appropriate
  • Installation and operational qualification
  • Calibration and verification
  • Preventive maintenance
  • Routine performance checks
  • Alarm verification
  • Cleaning and decontamination
  • Breakdown procedures
  • Service records
  • Replacement planning
  • Decommissioning records

The 2024 ASEBIR quality guidance specifically identifies equipment maintenance, physical space, air quality, staffing, training, and safe handling of gametes and embryos as critical elements of ART laboratory quality.

Equipment should never be considered reliable simply because it is functioning. Its performance must be demonstrated against defined acceptance criteria.

 

  1. Control Materials, Consumables and Suppliers

Consumables can directly interact with gametes and embryos. Consequently, supplier and material management should be treated as a critical quality activity.

Laboratories should establish procedures for purchasing, receiving, inspecting, storing, and approving critical materials. Where relevant, documentation should establish suitability, lot identification, expiry dates, storage conditions, and traceability.

Particular attention should be given to materials that come into direct or indirect contact with reproductive cells or embryos.

When a critical consumable changes, the laboratory should determine whether verification or validation is necessary before routine clinical use.

This is an important principle of modern QMS practice: change itself is a potential risk.

 

  1. Traceability and Patient Identification Are Non-Negotiable

Few quality requirements are more important in assisted reproduction than correct identification and traceability.

The laboratory must be able to establish an unambiguous connection between the patient, reproductive cells, embryos, storage location, procedures performed, materials used, and final disposition.

The updated ESHRE recommendations emphasize unique identification and traceability of patients and reproductive cells and tissues. They also call for secure, readable, accessible records and appropriate controls for electronic data and manual transcription.

Depending on the laboratory's system, controls may include:

  • Unique patient identifiers
  • Barcoding or electronic witnessing
  • Two-person verification where required
  • Defined witnessing points
  • Electronic audit trails
  • Cryostorage location records
  • Controlled access to records
  • Documented chain of custody

The objective is not simply to prevent an identification error. It is to make every critical step verifiable.

 

  1. Risk Management Should Be Proactive

Traditional quality control often asks: "Did something go wrong?"

A modern QMS should also ask: "What could go wrong, and how can we prevent it?"

Risk assessment can be applied to procedures, equipment, environmental conditions, biological-material handling, cryostorage, identification, software systems, and emergency scenarios.

High-risk processes should receive stronger controls.

For example, a laboratory can identify possible failure modes associated with incubator temperature deviation, gas supply interruption, cryogenic storage failure, patient identification, power failure, contamination, or loss of electronic records.

The 2026 ESHRE recommendations explicitly state that the IVF laboratory QMS should incorporate risk-management principles and that significant process changes should be identified and verified or validated.

Risk assessment should therefore be performed not only after an incident but also before introducing significant changes.

 

  1. Measure Performance With Meaningful Quality Indicators

A laboratory cannot improve what it does not measure.

Quality indicators should be selected according to the laboratory's activities and should provide useful information about process performance. Examples may include fertilization rates, embryo survival after warming, contamination events, equipment failures, identification incidents, deviations from environmental specifications, cycle cancellations attributable to laboratory factors, and other relevant operational indicators.

The objective is not to create a large number of statistics. It is to identify meaningful signals of process performance.

ESHRE recommends implementation and review of key performance indicators for quality control and quality assurance purposes.

Trend analysis is particularly important. A single deviation may be an isolated event; a gradual deterioration in performance may indicate an underlying problem requiring investigation.

 

  1. Non-Conformities Should Become Opportunities for Improvement

No complex laboratory environment is completely free of deviations. The difference between a weak and strong QMS is how the organization responds when something goes wrong.

Non-conformities, incidents, complaints, and adverse events should be documented, investigated, classified according to risk, and followed through to resolution.

Corrective and preventive action (CAPA) should address the underlying cause rather than merely correcting the immediate problem.

For example, replacing a failed component may solve an equipment problem, but it does not necessarily explain why the failure occurred or whether the same risk exists elsewhere.

The updated ESHRE recommendations call for documentation and analysis of non-conformities, emergencies, incidents, adverse events and complaints, together with appropriate CAPA and regular review of learning points.

A mature quality culture therefore treats incidents as data for organizational learning rather than simply as individual mistakes.

 

  1. Emergency Preparedness Must Be Tested

IVF laboratories require contingency plans because reproductive material may remain vulnerable even when routine laboratory activities stop.

Emergency procedures should address scenarios such as:

  • Power failure
  • Incubator failure
  • Cryogenic storage failure
  • Gas supply interruption
  • HVAC or environmental-control failure
  • Water or infrastructure failure
  • Fire or other facility emergencies
  • Information-system failure
  • Equipment breakdown
  • Staff shortages

A written emergency plan is necessary, but it is not sufficient. Staff should know their responsibilities, backup systems should be identified, and critical procedures should be tested periodically.

Emergency preparedness should also include documented criteria for escalation, communication, decision-making, and recovery.

 

  1. Auditing and Management Review Complete the Quality Cycle

Internal audits provide an independent assessment of whether procedures are being followed and whether the QMS remains effective.

Audits should examine both documentation and actual practice. A laboratory can have excellent SOPs while staff routinely follow different procedures. Conversely, staff may perform excellent work while the documentation is outdated.

Management review should periodically evaluate audit findings, quality indicators, incidents, CAPA, equipment performance, staffing, training, complaints, risks, and opportunities for improvement.

ISO 15189:2022 provides an internationally recognized framework for quality and competence in medical laboratories and is applicable to laboratories developing management systems and demonstrating competence.

For IVF laboratories, the exact regulatory and accreditation requirements will depend on jurisdiction and the services provided. Nevertheless, the principles of documented processes, competence, traceability, risk management, equipment control, and continual improvement are broadly applicable.

 

Conclusion

A high-quality IVF laboratory is not defined by sophisticated equipment alone. It is defined by the consistency, traceability, safety, competence, and control with which that equipment and expertise are integrated into daily practice.

A modern QMS brings these elements together. It establishes clear responsibilities, standardized procedures, competent personnel, controlled equipment and materials, robust identification and traceability, proactive risk management, meaningful performance indicators, effective CAPA, emergency preparedness, and continual improvement.

The 2026 ESHRE recommendations reinforce this comprehensive approach, covering virtually every major component of IVF laboratory practice—from organization and quality management to reproductive-cell traceability, consumables, embryo culture, embryo transfer, cryopreservation, embryo biopsy, and emergency procedures.

Ultimately, laboratory quality is not a document, certificate, or annual audit. It is a daily operational discipline. Every controlled procedure, verified device, documented deviation, trained professional, and traceable biological material contributes to the same objective: creating an IVF environment in which clinicians and patients can have greater confidence in the safety, reliability, and consistency of assisted reproduction care.

 

 

References

  1. World Health Organization. Laboratory Quality Management System: Handbook. WHO; 2011.
  2. ISO. ISO 15189:2022 — Medical laboratories: Requirements for quality and competence. International Organization for Standardization; 2022.
  3. ESHRE Good Practice in the IVF Lab Working Group. ESHRE recommendations on Good Practice in the IVF laboratory. Human Reproduction. 2026. doi:10.1093/humrep/deag096.
  4. Olmedo C, Veiga E, Sánchez L, et al. ASEBIR Quality Special Interest Group guidance for quality in assisted reproduction technology. Reproductive BioMedicine Online. 2024;48(4):103730. doi:10.1016/j.rbmo.2023.103730.
  5. World Health Organization. Quality Manual Template. WHO Laboratory Quality Management System resources.
  6. World Health Organization. Manual for Organizing a National External Quality Assessment Programme for Health Laboratories and Other Testing Sites. WHO; 2016.
  7. World Health Organization. Laboratory Quality Management. WHO.

 

Sharing in:
Rada Medical

RADA Medical

RADA, a brand owned by Behrad Rooyesh Royan Company, is a medical device manufacturer dedicated to supporting individuals and families on their journey to parenthood and advancing women’s health. Through safe and effective solutions for assisted reproduction and gynecological care, RADA empowers healthcare professionals to deliver reliable and high-quality patient care.

Copyright © 2026 Behrad Rooyesh Royan Co. (RADA brand) All rights reserved.
Development & Design | Donyadideh Company